Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Oral Solids Market Segmentation
1. Executive Summary
2. Global Oral Solids Market Introduction
2.1. Global Oral Solids Market - Taxonomy
2.2. Global Oral Solids Market - Definitions
2.2.1. Product
2.2.2. Release Mechanism
2.2.3. Region
3. Global Oral Solids Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
4. Global Oral Solids Market By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
4.1. Tablet
4.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3. Market Opportunity Analysis
4.2. Capsules
4.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.3. Market Opportunity Analysis
4.3. Powders & Granules (MT)
4.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3.3. Market Opportunity Analysis
5. Global Oral Solids Market By Release Mechanism, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Tablets
5.1.1. Immediate Release
5.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Modified Release
5.1.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Chewable Tablets
5.1.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Effervescent Tablets
5.1.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.2. Capsules
5.2.1. Controlled Release
5.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Enteric Release
5.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Others
5.2.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.3. Powders & Granules (MT)
5.3.1. Uncoated Powders & Granules
5.3.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.1.3. Market Opportunity Analysis
5.3.2. Coated Granules
5.3.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%)
5.3.2.3. Market Opportunity Analysis
6. Global Oral Solids Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. North America
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Europe
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Asia Pacific (APAC)
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Middle East and Africa (MEA)
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Latin America
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Global Oral Solids Market - Opportunity Analysis Index, By Release Mechanism, Product, and Region, 2023-2029
7. North America Oral Solids Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.1.1. Tablet
7.1.2. Capsules
7.1.3. Powders & Granules (MT)
7.2. Release Mechanism Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.2.1. Tablets
7.2.1.1. Immediate Release
7.2.1.2. Modified Release
7.2.1.3. Chewable Tablets
7.2.1.4. Effervescent Tablets
7.2.2. Capsules
7.2.2.1. Controlled Release
7.2.2.2. Enteric Release
7.2.2.3. Others
7.2.3. Powders & Granules (MT)
7.2.3.1. Uncoated Powders & Granules
7.2.3.2. Coated Granules
7.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.3.1. United States of America (USA)
7.3.2. Canada
8. Europe Oral Solids Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.1.1. Tablet
8.1.2. Capsules
8.1.3. Powders & Granules (MT)
8.2. Release Mechanism Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.2.1. Tablets
8.2.1.1. Immediate Release
8.2.1.2. Modified Release
8.2.1.3. Chewable Tablets
8.2.1.4. Effervescent Tablets
8.2.2. Capsules
8.2.2.1. Controlled Release
8.2.2.2. Enteric Release
8.2.2.3. Others
8.2.3. Powders & Granules (MT)
8.2.3.1. Uncoated Powders & Granules
8.2.3.2. Coated Granules
8.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.3.1. Germany
8.3.2. France
8.3.3. Italy
8.3.4. United Kingdom (UK)
8.3.5. Spain
8.3.6. Rest of EU
9. Asia Pacific (APAC) Oral Solids Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.1.1. Tablet
9.1.2. Capsules
9.1.3. Powders & Granules (MT)
9.2. Release Mechanism Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.2.1. Tablets
9.2.1.1. Immediate Release
9.2.1.2. Modified Release
9.2.1.3. Chewable Tablets
9.2.1.4. Effervescent Tablets
9.2.2. Capsules
9.2.2.1. Controlled Release
9.2.2.2. Enteric Release
9.2.2.3. Others
9.2.3. Powders & Granules (MT)
9.2.3.1. Uncoated Powders & Granules
9.2.3.2. Coated Granules
9.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.3.1. China
9.3.2. India
9.3.3. Australia and New Zealand (ANZ)
9.3.4. Japan
9.3.5. Rest of APAC
10. Middle East and Africa (MEA) Oral Solids Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1. Tablet
10.1.2. Capsules
10.1.3. Powders & Granules (MT)
10.2. Release Mechanism Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.2.1. Tablets
10.2.1.1. Immediate Release
10.2.1.2. Modified Release
10.2.1.3. Chewable Tablets
10.2.1.4. Effervescent Tablets
10.2.2. Capsules
10.2.2.1. Controlled Release
10.2.2.2. Enteric Release
10.2.2.3. Others
10.2.3. Powders & Granules (MT)
10.2.3.1. Uncoated Powders & Granules
10.2.3.2. Coated Granules
10.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of MEA
11. Latin America Oral Solids Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.1.1. Tablet
11.1.2. Capsules
11.1.3. Powders & Granules (MT)
11.2. Release Mechanism Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.2.1. Tablets
11.2.1.1. Immediate Release
11.2.1.2. Modified Release
11.2.1.3. Chewable Tablets
11.2.1.4. Effervescent Tablets
11.2.2. Capsules
11.2.2.1. Controlled Release
11.2.2.2. Enteric Release
11.2.2.3. Others
11.2.3. Powders & Granules (MT)
11.2.3.1. Uncoated Powders & Granules
11.2.3.2. Coated Granules
11.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of LA
12. Competition Landscape
12.1. Strategic Dashboard of Top Market Players
12.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
12.2.1. Abbvie Inc.
12.2.2. Alcami Corporation
12.2.3. Cambrex Corporation (Halo Pharma)
12.2.4. CMIC HOLDINGS Co., LTD.
12.2.5. Confab Laboratories Inc.
12.2.6. CordenPharma International
12.2.7. GENVION Corporation
12.2.8. Lonza Group AG
12.2.9. Mayne Pharma (Metrics Contract Services)
12.2.10. Pfizer Inc.
12.2.11. Pharma Tech Industries
12.2.12. Piramal Enterprises Ltd.
12.2.13. PNP Pharmaceuticals Inc.
12.2.14. ThermoFisher Scientific Inc. (Patheon N.V.)
12.2.15. Tower Laboratories Ltd.
13. Research Methodology
14. Key Assumptions and Acronyms
2. Global Oral Solids Market Introduction
2.1. Global Oral Solids Market - Taxonomy
2.2. Global Oral Solids Market - Definitions
2.2.1. Product
2.2.2. Release Mechanism
2.2.3. Region
3. Global Oral Solids Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
4. Global Oral Solids Market By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
4.1. Tablet
4.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3. Market Opportunity Analysis
4.2. Capsules
4.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.3. Market Opportunity Analysis
4.3. Powders & Granules (MT)
4.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3.3. Market Opportunity Analysis
5. Global Oral Solids Market By Release Mechanism, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Tablets
5.1.1. Immediate Release
5.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Modified Release
5.1.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Chewable Tablets
5.1.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Effervescent Tablets
5.1.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.2. Capsules
5.2.1. Controlled Release
5.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Enteric Release
5.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Others
5.2.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.3. Powders & Granules (MT)
5.3.1. Uncoated Powders & Granules
5.3.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.1.3. Market Opportunity Analysis
5.3.2. Coated Granules
5.3.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%)
5.3.2.3. Market Opportunity Analysis
6. Global Oral Solids Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. North America
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Europe
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Asia Pacific (APAC)
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Middle East and Africa (MEA)
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Latin America
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Global Oral Solids Market - Opportunity Analysis Index, By Release Mechanism, Product, and Region, 2023-2029
7. North America Oral Solids Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.1.1. Tablet
7.1.2. Capsules
7.1.3. Powders & Granules (MT)
7.2. Release Mechanism Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.2.1. Tablets
7.2.1.1. Immediate Release
7.2.1.2. Modified Release
7.2.1.3. Chewable Tablets
7.2.1.4. Effervescent Tablets
7.2.2. Capsules
7.2.2.1. Controlled Release
7.2.2.2. Enteric Release
7.2.2.3. Others
7.2.3. Powders & Granules (MT)
7.2.3.1. Uncoated Powders & Granules
7.2.3.2. Coated Granules
7.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.3.1. United States of America (USA)
7.3.2. Canada
8. Europe Oral Solids Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.1.1. Tablet
8.1.2. Capsules
8.1.3. Powders & Granules (MT)
8.2. Release Mechanism Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.2.1. Tablets
8.2.1.1. Immediate Release
8.2.1.2. Modified Release
8.2.1.3. Chewable Tablets
8.2.1.4. Effervescent Tablets
8.2.2. Capsules
8.2.2.1. Controlled Release
8.2.2.2. Enteric Release
8.2.2.3. Others
8.2.3. Powders & Granules (MT)
8.2.3.1. Uncoated Powders & Granules
8.2.3.2. Coated Granules
8.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.3.1. Germany
8.3.2. France
8.3.3. Italy
8.3.4. United Kingdom (UK)
8.3.5. Spain
8.3.6. Rest of EU
9. Asia Pacific (APAC) Oral Solids Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.1.1. Tablet
9.1.2. Capsules
9.1.3. Powders & Granules (MT)
9.2. Release Mechanism Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.2.1. Tablets
9.2.1.1. Immediate Release
9.2.1.2. Modified Release
9.2.1.3. Chewable Tablets
9.2.1.4. Effervescent Tablets
9.2.2. Capsules
9.2.2.1. Controlled Release
9.2.2.2. Enteric Release
9.2.2.3. Others
9.2.3. Powders & Granules (MT)
9.2.3.1. Uncoated Powders & Granules
9.2.3.2. Coated Granules
9.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.3.1. China
9.3.2. India
9.3.3. Australia and New Zealand (ANZ)
9.3.4. Japan
9.3.5. Rest of APAC
10. Middle East and Africa (MEA) Oral Solids Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1. Tablet
10.1.2. Capsules
10.1.3. Powders & Granules (MT)
10.2. Release Mechanism Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.2.1. Tablets
10.2.1.1. Immediate Release
10.2.1.2. Modified Release
10.2.1.3. Chewable Tablets
10.2.1.4. Effervescent Tablets
10.2.2. Capsules
10.2.2.1. Controlled Release
10.2.2.2. Enteric Release
10.2.2.3. Others
10.2.3. Powders & Granules (MT)
10.2.3.1. Uncoated Powders & Granules
10.2.3.2. Coated Granules
10.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of MEA
11. Latin America Oral Solids Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.1.1. Tablet
11.1.2. Capsules
11.1.3. Powders & Granules (MT)
11.2. Release Mechanism Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.2.1. Tablets
11.2.1.1. Immediate Release
11.2.1.2. Modified Release
11.2.1.3. Chewable Tablets
11.2.1.4. Effervescent Tablets
11.2.2. Capsules
11.2.2.1. Controlled Release
11.2.2.2. Enteric Release
11.2.2.3. Others
11.2.3. Powders & Granules (MT)
11.2.3.1. Uncoated Powders & Granules
11.2.3.2. Coated Granules
11.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of LA
12. Competition Landscape
12.1. Strategic Dashboard of Top Market Players
12.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
12.2.1. Abbvie Inc.
12.2.2. Alcami Corporation
12.2.3. Cambrex Corporation (Halo Pharma)
12.2.4. CMIC HOLDINGS Co., LTD.
12.2.5. Confab Laboratories Inc.
12.2.6. CordenPharma International
12.2.7. GENVION Corporation
12.2.8. Lonza Group AG
12.2.9. Mayne Pharma (Metrics Contract Services)
12.2.10. Pfizer Inc.
12.2.11. Pharma Tech Industries
12.2.12. Piramal Enterprises Ltd.
12.2.13. PNP Pharmaceuticals Inc.
12.2.14. ThermoFisher Scientific Inc. (Patheon N.V.)
12.2.15. Tower Laboratories Ltd.
13. Research Methodology
14. Key Assumptions and Acronyms
• Abbvie Inc.
• Alcami Corporation
• Cambrex Corporation (Halo Pharma)
• CMIC HOLDINGS Co., LTD.
• Confab Laboratories Inc.
• CordenPharma International
• GENVION Corporation
• Lonza Group AG
• Mayne Pharma (Metrics Contract Services)
• Pfizer Inc.
• Pharma Tech Industries
• Piramal Enterprises Ltd.
• PNP Pharmaceuticals Inc.
• ThermoFisher Scientific Inc. (Patheon N.V.)
• Tower Laboratories Ltd.
• Alcami Corporation
• Cambrex Corporation (Halo Pharma)
• CMIC HOLDINGS Co., LTD.
• Confab Laboratories Inc.
• CordenPharma International
• GENVION Corporation
• Lonza Group AG
• Mayne Pharma (Metrics Contract Services)
• Pfizer Inc.
• Pharma Tech Industries
• Piramal Enterprises Ltd.
• PNP Pharmaceuticals Inc.
• ThermoFisher Scientific Inc. (Patheon N.V.)
• Tower Laboratories Ltd.